Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- MSM -12.9%, RH -11.9%, NUE -2.4% (guidance), POWW -1.6%
Other news:
- QXO -52.8% (announces $3.5 billion private placement composed of common stock and warrants)
- RZLT -16.5% (prices offering of $60 million of common stock and pre-funded warrants)
- ISSC -5.9% (issues response to Christopher Harborne non-binding indication of interest)
- COGT -4.9% (announces additional clinical data from part 1 of its ongoing summit trial evaluating bezuclastinib in patients with nonadvanced systemic mastocytosis)
- LOGI -3.1% (names interim CFO)
- FAST -2.9% (in sympathy with weak MSM guidance)
- RARE -2.8% (prices $350 mln offering consisting of common stock and pre-funded warrants)
- TUSK -2% (files $500 mln share offering; also files for offering by selling shareholders)
- GWW -1.9% (in sympathy with weak MSM guidance)
- MUFG -1.9% (confirms update regarding the Securities and Sxchange Surveillance Commission's recommendation for administrative action)
- RNA -1.6% (prices offering of 10.55 mln shares of common stock at $38.00 per share)
- IIPR -1.5% (increases quarterly dividend 4.4% to $1.90/share from $1.82/share)
- ON -1.1% (to reduce global workforce by ~1,000 employees)
Analyst comments:
- EGHT -7.3% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- BAND -5.7% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- TWLO -3.1% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- HBAN -2.1% (downgraded to Underweight from Neutral at Piper Sandler)